123 related articles for article (PubMed ID: 17870025)
1. Pathology of chronic lymphocytic leukemia: an update.
Inamdar KV; Bueso-Ramos CE
Ann Diagn Pathol; 2007 Oct; 11(5):363-89. PubMed ID: 17870025
[TBL] [Abstract][Full Text] [Related]
2. Breed Distribution and Clinical Characteristics of B Cell Chronic Lymphocytic Leukemia in Dogs.
Bromberek JL; Rout ED; Agnew MR; Yoshimoto J; Morley PS; Avery AC
J Vet Intern Med; 2016; 30(1):215-22. PubMed ID: 26740174
[TBL] [Abstract][Full Text] [Related]
3. An overview of prognostic markers in patients with CLL.
Braish J; Cerchione C; Ferrajoli A
Front Oncol; 2024; 14():1371057. PubMed ID: 38817892
[TBL] [Abstract][Full Text] [Related]
4. Clinical application of targeted and genome-wide technologies: can we predict treatment responses in chronic lymphocytic leukemia?
Alsolami R; Knight SJ; Schuh A
Per Med; 2013 Jun; 10(4):361-376. PubMed ID: 24611071
[TBL] [Abstract][Full Text] [Related]
5. Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment.
Hallek M
Am J Hematol; 2015 May; 90(5):446-60. PubMed ID: 25908509
[TBL] [Abstract][Full Text] [Related]
6. Cellular origin and pathophysiology of chronic lymphocytic leukemia.
Seifert M; Sellmann L; Bloehdorn J; Wein F; Stilgenbauer S; Dürig J; Küppers R
J Exp Med; 2012 Nov; 209(12):2183-98. PubMed ID: 23091163
[TBL] [Abstract][Full Text] [Related]
7. The pathogenesis of chronic lymphocytic leukemia.
Zhang S; Kipps TJ
Annu Rev Pathol; 2014; 9():103-18. PubMed ID: 23987584
[TBL] [Abstract][Full Text] [Related]
8. Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment.
Hallek M
Am J Hematol; 2017 Sep; 92(9):946-965. PubMed ID: 28782884
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.
Hallek M
Am J Hematol; 2019 Nov; 94(11):1266-1287. PubMed ID: 31364186
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic leukaemia.
Scarfò L; Ferreri AJ; Ghia P
Crit Rev Oncol Hematol; 2016 Aug; 104():169-82. PubMed ID: 27370174
[TBL] [Abstract][Full Text] [Related]
11. Differential diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma and other indolent lymphomas, including mantle cell lymphoma.
Yoshino T; Tanaka T; Sato Y
J Clin Exp Hematop; 2020 Dec; 60(4):124-129. PubMed ID: 32249238
[TBL] [Abstract][Full Text] [Related]
12. [Current diagnosis and treatment of chronic lymphocytic leukaemia].
Cramer P; von Tresckow J; Eichhorst B; Hallek M
Dtsch Med Wochenschr; 2020 Aug; 145(16):1139-1144. PubMed ID: 32791549
[TBL] [Abstract][Full Text] [Related]
13. Chronic lymphocytic leukemia: staging and prognostic factors.
Zwiebel JA; Cheson BD
Semin Oncol; 1998 Feb; 25(1):42-59. PubMed ID: 9482526
[TBL] [Abstract][Full Text] [Related]
14. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.
Hallek M; Cheson BD; Catovsky D; Caligaris-Cappio F; Dighiero G; Döhner H; Hillmen P; Keating M; Montserrat E; Chiorazzi N; Stilgenbauer S; Rai KR; Byrd JC; Eichhorst B; O'Brien S; Robak T; Seymour JF; Kipps TJ
Blood; 2018 Jun; 131(25):2745-2760. PubMed ID: 29540348
[TBL] [Abstract][Full Text] [Related]
15. The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders.
Al-Zubaidi HK; Hughes SF
Br J Biomed Sci; 2023; 80():11573. PubMed ID: 37822353
[No Abstract] [Full Text] [Related]
16. Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target.
Cuesta-Mateos C; Brown JR; Terrón F; Muñoz-Calleja C
Front Immunol; 2021; 12():662866. PubMed ID: 33841445
[TBL] [Abstract][Full Text] [Related]
17. Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemia.
Basabaeen AA; Abdelgader EA; BaHashwan OS; Babekir EA; Abdelateif NM; Bamusa SA; Abdelrahim SO; Altayeb OA; Fadul EA; Ibrahim IK
BMC Res Notes; 2019 May; 12(1):282. PubMed ID: 31122288
[TBL] [Abstract][Full Text] [Related]
18. ZAP-70 expression is associated with increased CD4 central memory T cells in chronic lymphocytic leukemia: cross-sectional study.
Correia RP; Matos E Silva FA; Bacal NS; Campregher PV; Hamerschlak N; Amarante-Mendes GP
Hematol Transfus Cell Ther; 2018; 40(4):317-325. PubMed ID: 30370409
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Caspase-9b and PP2Acα2 as potential biomarkers for chronic lymphocytic leukemia.
Domínguez-Berrocal L; Zhang X; Zini JM; Fominaya J; Rebollo A; Bravo J
Biomark Res; 2016; 4():9. PubMed ID: 27152197
[TBL] [Abstract][Full Text] [Related]
20. Phorbol myristate acetate, but not CD40L, induces the differentiation of CLL B cells into Ab-secreting cells.
Ghamlouch H; Ouled-Haddou H; Guyart A; Regnier A; Trudel S; Claisse JF; Fuentes V; Royer B; Marolleau JP; Gubler B
Immunol Cell Biol; 2014 Aug; 92(7):591-604. PubMed ID: 24797583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
